Drug Atlas

NDC 50268-225 – Doxazosin

Doxazosin Mesylate 8 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC50268-225

Product details

Brand name: Doxazosin
Generic name: Doxazosin
Labeler: AvPAK
Dosage form: Tablet
Route: Oral
Marketing category: ANDA · ANDA075580
Marketed since: May 9, 2022
Listing expires: December 31, 2027
Pharmacologic class: alpha-Adrenergic Blocker

Active ingredients

Doxazosin Mesylate 8 mg/1

Uses, dosage, side effects and warnings for Doxazosin →

Package NDC codes (1)

Package NDC	Description	Since
50268-225-15	50 BLISTER PACK in 1 BOX (50268-225-15) / 1 TABLET in 1 BLISTER PACK (50268-225-11)	May 9, 2022

Other Doxazosin products

50090-8055 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
50090-2153 Doxazosin Mesylate 1 mg/1 · Tablet · A-S Medication Solutions
50090-3143 Doxazosin Mesylate 8 mg/1 · Tablet · A-S Medication Solutions
50090-7803 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
50090-6298 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
50090-2172 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
50090-5773 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
50090-0701 Doxazosin Mesylate 1 mg/1 · Tablet · A-S Medication Solutions
50090-0704 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
50090-3927 Doxazosin Mesylate 4 mg/1 · Tablet · A-S Medication Solutions
50090-6401 Doxazosin Mesylate 2 mg/1 · Tablet · A-S Medication Solutions
16729-211 Doxazosin Mesylate 1 mg/1 · Tablet · Accord Healthcare Inc.